Macrophage-activating factor (MAF)
Taniyama, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 755-758
1999
ISSN/ISBN: 0047-1852 PMID: 10635962 Document Number: 509836
Document emailed within 1 workday
Related Documents
Kelso, A.; Glasebrook, A.L. 1984: Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones Journal of Immunology 132(6): 2924-2931Horton, J.E.; Oppenheim, J.J.; Mergenhagen, S.E.; Raisz, L.G. 1974: Macrophage-lymphocyte synergy in the production of osteoclast activating factor Journal of Immunology 113(4): 1278-1287
Cameron, D.J. 1985: Impairment of macrophage activating factor (MAF) production in lymphocytes from cancer patients Japanese Journal of Experimental Medicine 55(1): 13-19
Mohamad, S.B.; Nagasawa, H.; Uto, Y.; Hori, H. 2002: Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities Anticancer Research 22(6c): 4297-4300
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Postlethwaite, A.E.; Kang, A.H. 1976: Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor Journal of Immunology 117(5 Part 1): 1651-1655
Fujikawa, Y.; Sabokbar, A.; Neale, S.D.; Itonaga, I.; Torisu, T.; Athanasou, N.A. 2001: The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells Bone 28(3): 261-267
Hirashima, M.; Tashiro, K.; Sakata, K.; Yoshimura, T.; Hayashi, H. 1984: Difference in requirement of macrophage products for concanavalin A-induced production of eosinophil chemotactic factor and macrophage chemotactic factor from guinea pig lymphocytes in vitro Journal of Immunology 133(4): 2012-2017
Brach, M.A.; Arnold, C.; Kiehntopf, M.; Gruss, H.J.; Herrmann, F. 1993: Transcriptional activation of the macrophage colony-stimulating factor gene by IL-2 is associated with secretion of bioactive macrophage colony-stimulating factor protein by monocytes and involves activation of the transcription factor NF-kappa B Journal of Immunology 150(12): 5535-5543
Takahashi, M. 1999: Macrophage chemotactic factor and macrophage migration inhibitory factor Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 752-754
Takahashi, M. 2005: Macrophage chemotactic factor and macrophage migration inhibitory factor Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 41-43
Taniyama, T. 1990: Cytotoxic activity of macrophage activating factors Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 881-883
Jakoniuk, P.; Sacha, P.; Borowski, J. 1989: Isolation of macrophage-activating phospholipid from Listeria monocytogenes Medycyna Doswiadczalna i Mikrobiologia 41(1): 15-21
Moore, R.N.; Rouse, B.T. 1983: Enhanced responsiveness of committed macrophage precursors to macrophage-type colony-stimulating factor (CSF-1) induced in vitro by interferons alpha + beta 1 Journal of Immunology 131(5): 2374-2378
Kountouras, J.; Boura, P.; Tsapas, G. 1998: In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients Hepato-Gastroenterology 45(24): 2295-2302
Lian, D.; Ma, G.; Sun, C.; Mao, W. 2016: Effect of synergistic polarization macrophage modulated by N-terminal domain of a2 vacuolar ATPase and macrophage colony stimulating factor on proliferation of gastric cancer cells Zhonghua Wei Chang Wai Ke Za Zhi 19(2): 209-215
Farr, R.S.; Wardlow, M.L.; Cox, C.P.; Meng, K.E.; Greene, D.E. 1983: Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Federation Proceedings 42(14): 3120-3122
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320